BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 24070715)

  • 21. False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making.
    Pinsky PF; Bellinger CR; Miller DP
    J Med Screen; 2018 Jun; 25(2):110-112. PubMed ID: 28929865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application value of low-dose computed tomography for the screening of lung cancer in high-risk group].
    Lei Y; Chen BJ; Zeng L; Li WM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 43(4):584-7. PubMed ID: 22997901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
    Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reviewing risks and benefits of low-dose computed tomography screening for lung cancer.
    Chopra I; Chopra A; Bias TK
    Postgrad Med; 2016; 128(2):254-61. PubMed ID: 26680693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.
    Aberle DR; Abtin F; Brown K
    J Clin Oncol; 2013 Mar; 31(8):1002-8. PubMed ID: 23401434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.
    Goulart BH; Ramsey SD
    Oncologist; 2013; 18(8):941-6. PubMed ID: 23873718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A National Survey of Pulmonologists' Views on Low-Dose Computed Tomography Screening for Lung Cancer.
    Iaccarino JM; Clark J; Bolton R; Kinsinger L; Kelley M; Slatore CG; Au DH; Wiener RS
    Ann Am Thorac Soc; 2015 Nov; 12(11):1667-75. PubMed ID: 26368003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for lung cancer: A systematic review and meta-analysis.
    Usman Ali M; Miller J; Peirson L; Fitzpatrick-Lewis D; Kenny M; Sherifali D; Raina P
    Prev Med; 2016 Aug; 89():301-314. PubMed ID: 27130532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
    Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
    Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose computed tomography screening for lung cancer: how strong is the evidence?
    Woolf SH; Harris RP; Campos-Outcalt D
    JAMA Intern Med; 2014 Dec; 174(12):2019-22. PubMed ID: 25317533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung cancer screening with low-dose computed tomography.
    Chiles C
    Radiol Clin North Am; 2014 Jan; 52(1):27-46. PubMed ID: 24267709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
    Silva M; Pastorino U; Sverzellati N
    Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of lung cancer screening with low-dose computed tomography for Medicare beneficiaries.
    Wood DE
    JAMA Intern Med; 2014 Dec; 174(12):2016-8. PubMed ID: 25317992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians.
    Ersek JL; Eberth JM; McDonnell KK; Strayer SM; Sercy E; Cartmell KB; Friedman DB
    Cancer; 2016 Aug; 122(15):2324-31. PubMed ID: 27294476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.
    McCunney RJ; Li J
    Chest; 2014 Mar; 145(3):618-24. PubMed ID: 24590022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rationale for, and design of, a lung cancer screening program.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79(5):337-45. PubMed ID: 22550076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated.
    Mortani Barbosa EJ
    Acad Radiol; 2015 Aug; 22(8):976-82. PubMed ID: 25772581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for lung cancer: for patients at increased risk for lung cancer, it works.
    Jett JR; Midthun DE
    Ann Intern Med; 2011 Oct; 155(8):540-2. PubMed ID: 21893615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer screening with low dose CT: experience at Campus Bio-Medico of Rome on 1500 patients.
    Crucitti P; Gallo IF; Santoro G; Mangiameli G
    Minerva Chir; 2015 Dec; 70(6):393-9. PubMed ID: 25700151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of selected factors on the attendance of the high-risk population in the early lung cancer detection program.
    Zakrzewska A; Szczepanowska M; Książek J; Biadacz I; Dziedzic R; Jelitto-Górska M; Rzyman W
    Pneumonol Alergol Pol; 2014; 82(1):25-31. PubMed ID: 24391068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.